INS and Hepatic steatosis: Fasting insulin levels, islet area and insulin to glucagon positive cell ratio also increased with RvE1 treatment (Figs 5b and S4b,d) but no differences were noted in hepatic steatosis or VAT morphology (Figure S4e–h).